A5060291076- Cannabis and Cannabinoid Research
- Musculoskeletal pain and rehabilitation
- Pediatric Pain Management Techniques
- Substance Abuse Treatment and Outcomes
- Opioid Use Disorder Treatment
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Prenatal Substance Exposure Effects
- Psychedelics and Drug Studies
- School Health and Nursing Education
- Liver Diseases and Immunity
- Bipolar Disorder and Treatment
- Immune Response and Inflammation
- S100 Proteins and Annexins
- Infant Development and Preterm Care
- Blood disorders and treatments
- Diabetes Management and Education
- Sleep and related disorders
- Alcohol Consumption and Health Effects
- Anesthesia and Pain Management
- Rheumatoid Arthritis Research and Therapies
- Cardiac Arrest and Resuscitation
- HIV, Drug Use, Sexual Risk
- Complementary and Alternative Medicine Studies
- Homelessness and Social Issues
- Heart Rate Variability and Autonomic Control
University of Michigan
2022-2025
Centers for Disease Control and Prevention
2024
Arthritis Society
2023
McGill University
2023
Arthritis Foundation
2023
Michigan Medicine
2023
As medical cannabis availability increases, up-to-date trends in licensure can inform clinical policy and care. To describe current the United States. Ecological study with repeated measures. Publicly available state registry data from 2020 to 2022. People licenses clinicians authorizing Total patient volume prevalence per 10 000 persons total population, symptoms or conditions qualifying patients for (that is, patient-reported conditions), number of clinicians. In 2022, 39 jurisdictions...
This survey study characterizes past-year use prevalence and factors associated with of cannabidiol, cannabigerol, cannabinol, Δ8-tetrahydrocannabinol among US adults.
Abstract Introduction Chronic pain is common among Veterans, some of whom use cannabis for pain. We conducted a feasibility pilot study novel coaching intervention to help Veterans optimize medical products management (NCT06320470). Methods The drew from scientific literature, consultation with experts, Veteran input via Community Advisory Board, and tenets motivational interviewing. Participants were chronic who endorsed current or interest in using management. received up 4 individual...
Chronic pain has economic costs on par with cardiovascular disease, diabetes, and cancer. Despite this impact the health care system increasing awareness of relationship between mortality, efforts to identify simple symptom-based risk factors for development pain, particularly in children, have fallen short. This is critically important as that manifests during childhood often persists into adulthood. To date, no longitudinal studies examined symptoms pain-free children presage a new,...
Neutrophil hyperactivity and neutrophil extracellular trap release (NETosis) appear to play important roles in the pathogenesis of thromboinflammatory autoimmune disease known as antiphospholipid syndrome (APS). The understanding metabolism has advanced tremendously past decade, accumulating evidence suggests that a variety metabolic pathways guide activities health disease. Our previous work characterizing transcriptome APS neutrophils revealed genes related glycolysis, glycogenolysis,...
Understanding how medical cannabis (MC) use is integrated into practice for rheumatic disease management essential. We characterized rationale MC use, patient-physician interactions around MC, and patterns among people with conditions in the US Canada.We surveyed 3406 participants Canada, 1727 completing survey (50.7% response rate). assessed disclosure of to health care providers, authorization by investigated factors associated providers versus Canada.Overall, 54.9% respondents 78.0%...
Objective There are numerous reports of people substituting medical cannabis (MC) for medications. Our obejctive was to investigate the degree which this substitution occurs among with rheumatic conditions. Methods In a secondary analysis from cross‐sectional survey conducted patient advocacy groups in US and Canada, we investigated MC use medication We subgrouped by whether participants substituted medications differences perceived symptom changes patterns, including methods ingestion,...
While thrombosis and pregnancy loss are the best-known clinical features of antiphospholipid syndrome (APS), many patients also exhibit "extra-criteria" manifestations, such as thrombocytopenia. The mechanisms that drive APS thrombocytopenia not completely understood, no biomarkers available for predicting antibody (aPL)-mediated Calprotectin is a heterodimer S100A8 S100A9 abundant in neutrophil cytoplasm released upon proinflammatory activation. Here, we sought to evaluate presence,...
Objectives. To investigate characteristics of data reported in US medical cannabis registries across states. Methods. Data included 2021 registry reports from 34 states, Puerto Rico, and the District Columbia (hereafter, states) with active programs. The were manually coded into domains subcategories, including information related to patients (e.g., number, demographics), authorizing clinicians, sales content, revenue), license tracking, health safety outcomes. Results. Among 36 97% total...
This study assessed patient-reported outcomes (PROs) in individuals with persistently positive antiphospholipid antibodies (aPL) to better understand how living aPL may affect their quality of life.Patients completed Patient-Reported Outcomes Measurement Information System Physical Function (PF) and Cognitive (CF) Short Forms as well the pain intensity (PI) rating (scale 1-10). Patients were characterized for demographics, clinical manifestations syndrome (APS), cardiovascular risk factors,...